TriRx, a contract development and manufacturing organization, completed the acquisition of facility in Kansas from Elanco Animal Health, a pharmaceutical company. Financial terms were not disclosed. "We are excited to complete the transaction to acquire the Shawnee facility and look forward to continuing to build on the strategic partnership between Elanco, TriRx, the workforce, and the local community in Shawnee, Kansas. TriRx will transition the Elanco Center of Manufacturing Excellence to a Global Center of Excellence serving the pharmaceutical contract development and manufacturing market," Timothy Tyson, TriRx Chairman & CEO.